Pfizer · NSE: PFIZER · BSE: 500680
Q1 FY24 results · Apr–Jun 2023
Pfizer reported revenue from operations of ₹531.36 crore (down 10.4% from Q1 FY23) and net profit of ₹93.53 crore (up 187.3% from Q1 FY23) for Q1 FY24 (Apr–Jun 2023), on a standalone basis.
| Item | Q1 FY24 | Q1 FY23 | YoY | Q4 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 531.36 | 592.90 | −10.4% | 572.64 | −7.2% |
| Other income | 33.46 | 18.02 | +85.7% | 31.38 | +6.6% |
| Total income | 564.82 | 610.92 | −7.5% | 604.02 | −6.5% |
| Profit before tax | 125.75 | 43.39 | +189.8% | 164.72 | −23.7% |
| Net profit for the period | 93.53 | 32.55 | +187.3% | 129.65 | −27.9% |
| EPS, basic (₹) | 20.44 | 7.11 | +187.5% | 28.34 | not comparable |
| Net margin (%) | 17.6 | 5.5 | 22.6 |
Standalone
- Filed with BSE
- 11 Aug 2023, 16:41 IST
- Board meeting
- 11 Aug 2023
- Period
- 01 Apr 2023 to 30 Jun 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE